News
-
-
COMMUNIQUÉ DE PRESSE
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
aap Implantate AG completes amendment of bond terms allowing bondholders to convert bonds into shares. Conversion period until May 29, 2024. For more information, visit https://www.aap.de/investoren/wandelschuldverschreibung -
-
-
COMMUNIQUÉ DE PRESSE
aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
aap Implantate AG reports 5.6% sales growth in Q1 2024, positive developments across all regions & progress in human clinical trial of antibacterial implant technology -
-
-
COMMUNIQUÉ DE PRESSE
aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
aap Implantate AG successfully completes 10% capital increase at EUR 1.10, raising EUR 986,311.70 for human clinical trial of antibacterial implant technology -
-
